Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. | 53,832 | reported | 06 May 2022 | tx 1+53,832 |
| Amylyx Pharmaceuticals, Inc. | 25,000 | reported | 05 Jun 2025 | tx 6+98,332 |
| Adicet Bio, Inc. | 14,414 | reported | 03 Jun 2020 | tx 2+28,828 |
| Apellis Pharmaceuticals, Inc. | 0 | reported | 14 May 2026 | tx 25+115,792−167,580 |
| COVETRUS, INC. | 0 | reported | 13 Oct 2022 | tx 7+36,188−36,188 |
| ADVANCED MAGNETICS INC | 0 | reported | 16 Nov 2020 | tx 9+51,417−51,417 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 30,666 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3,062 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 5,744 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7,961 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3,544 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3,877 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 14,684 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 37,500 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 11,199 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 8,554 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7,441 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 27,600 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 5,748 | — | deriv |
| 01 Jan 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 7,961 | 0.00 USD | |
| 01 Jan 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 14,684 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 01 Jan 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 6,267 | 0.00 USD | |
| 01 Jan 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 11,199 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 3,341 | 0.00 USD | |
| 01 Jan 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 5,748 | 59.86 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 16,985 | 0.00 USD | deriv |
| 01 Jan 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 3,867 | 0.00 USD | |
| 01 Jan 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 7,441 | 0.00 USD | deriv |
| 13 Oct 2022 | OTHER | COVETRUS, INC. | 13,275 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 10 Aug 2021.